Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
K Jin, L Teng, Y Shen, K He, Z Xu, G Li - Clinical and Translational …, 2010 - Springer
Mouse cancer models have consistently been used to qualify new anticancer drugs in the
development of human clinical trials. Rodent tumour models currently being used and which …
development of human clinical trials. Rodent tumour models currently being used and which …
[HTML][HTML] LncRNA UCA1 in anti-cancer drug resistance
H Wang, Z Guan, K He, J Qian, J Cao, L Teng - Oncotarget, 2017 - ncbi.nlm.nih.gov
The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1
(UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression …
(UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression …
[HTML][HTML] Protease-activated receptors in cancer: A systematic review
N Han, K Jin, K He, J Cao, L Teng - Oncology letters, 2011 - spandidos-publications.com
The traditional view of the role of proteases in tumor growth, progression and metastasis has
significantly changed. Apart from their contribution to cancer progression, it is evident that a …
significantly changed. Apart from their contribution to cancer progression, it is evident that a …
[HTML][HTML] Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction …
H Jiang, X Yu, N Li, M Kong, Z Ma, D Zhou… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors have greatly improved the prognoses of diverse advanced
malignancies, including gastric and gastroesophageal junction (G/GEJ) cancer. However …
malignancies, including gastric and gastroesophageal junction (G/GEJ) cancer. However …
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 …
W Wang, X Su, K He, Y Wang, H Wang, H Wang… - Cancer, 2016 - Wiley Online Library
BACKGROUND Bilaterality is common in papillary thyroid cancer (PTC), but its clinical and
prognostic implications are still controversial, and it remains unclear whether its behavior is …
prognostic implications are still controversial, and it remains unclear whether its behavior is …
[HTML][HTML] LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
H Wang, M Wu, Y Lu, K He, X Cai, X Yu, J Lu… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Long non-coding RNAs (lncRNAs) have been implicated in the pathogenesis of gastric
cancer; however, their mechanisms of action remain largely unknown. The aim of this study …
cancer; however, their mechanisms of action remain largely unknown. The aim of this study …
[HTML][HTML] Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
G Li, J Zhang, K Jin, K He, Y Zheng, X Xu, H Wang… - Molecular …, 2013 - Elsevier
Acquired tamoxifen (TAM) resistance limits the therapeutic benefit of TAM in patients with
hormone-dependent breast cancer. The switch from estrogen-dependent to growth factor …
hormone-dependent breast cancer. The switch from estrogen-dependent to growth factor …
[HTML][HTML] Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
J Lu, G Li, K He, W Jiang, C Xu, Z Li, H Wang… - Journal of translational …, 2015 - Springer
Background Aberrated activation of cMet in gastric cancer contributes to tumor growth,
angiogenesis and metastasis. cMet-overexpressing gastric cancer has a poor prognosis …
angiogenesis and metastasis. cMet-overexpressing gastric cancer has a poor prognosis …
[HTML][HTML] COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
X Jiang, M Wu, X Xu, L Zhang… - Molecular …, 2019 - spandidos-publications.com
Dysregulation of collagen type XII α1 chain (COL12A1) has been found in several cancer
types and could be involved in tumor progression. However, its clinical significance in …
types and could be involved in tumor progression. However, its clinical significance in …
[HTML][HTML] Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET …
H Wang, J Lu, J Tang, S Chen, K He, X Jiang, W Jiang… - BMC cancer, 2017 - Springer
Background Targeted therapies are emerging treatment options for gastric cancer (GC).
Patient-derived tumor xenograft (PDX) models of GC closely retain the features of the …
Patient-derived tumor xenograft (PDX) models of GC closely retain the features of the …